Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

PRE 14A

SEC Filing Details

Document Details

Filing Date
Apr 21, 2017
Document Date
Jun 18, 2017
Form Description

A preliminary proxy statement providing notification matters to be brought to a vote

Filing Group
Proxy Filings
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved